Zydus Pharmaceuticals (USA) Inc recalls
Zydus Pharmaceuticals (USA) Inc is named on 24 recalls in Recall Relay's records since November 2023, from FDA (45 recalled products: FDA lists each product as its own recall); the most recent was October 1, 2026.
All 45 recalled products, newest first.
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls Hydrocortisone Sodium Succinate for InjectionFailed Impurities/Degradation Specifications.
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls Mirabegron Extended-Release TabletsCGMP: Due to Out of Specification (OOS) result for N-Nitroso Mirabegron impurity.
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls Erythromycin TabletsCGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls Erythromycin TabletsCGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls Icosapent Ethyl CapsulesFailed Tablet/Capsule specifications: Red dots inside capsule and melted capsule caused by oxidized Icosapent ethyl, the active ingredient.
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls Icosapent Ethyl capsulesSubpotent Drug: Due to oxidation caused by leakage of the contents of the capsules
-
Class IIIofficial
Zydus Pharmaceuticals (USA) Inc recalls traZODONE Hydrochloride TabletsFailed Tablet/Capsule Specifications: Product complaint received that some tablets had a dent on the plain side of the tablet surface.
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls Bromocriptine Mesylate CapsulesFailed Impurities/Degradation Specifications: Out of Specification (OOS) result reported for 2- Bromoergine impurity of Bromocriptine Mesylate Capsules.
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls clomiPRAMINE HydrochloridecGMP deviations: an observed Out of Specification of Nitrosamine Drug Substance-Related Impurities (NDSRIs), N-Nitroso Desmethyl-Clomipramine, above the FDA acceptable intake limit.
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls clomiPRAMINE HydrochloridecGMP deviations: an observed Out of Specification of Nitrosamine Drug Substance-Related Impurities (NDSRIs), N-Nitroso Desmethyl-Clomipramine, above the FDA acceptable intake limit.
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls clomiPRAMINE HydrochloridecGMP deviations: an observed Out of Specification of Nitrosamine Drug Substance-Related Impurities (NDSRIs), N-Nitroso Desmethyl-Clomipramine, above the FDA acceptable intake limit.
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls Entecavir TabletsFailed impurity/degradation specifications:Out of Specification result for an individual organic impurity
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls Entecavir TabletsFailed impurity/degradation specifications:Out of Specification result for an individual organic impurity
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls Entecavir TabletsFailed Impurity/Degradation Specifications
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls Entecavir TabletsFailed Impurity/Degradation Specifications
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls Chlorpromazine Hydrochloride TabletsCGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls Chlorpromazine Hydrochloride TabletsCGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls Chlorpromazine Hydrochloride TabletsCGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls Chlorpromazine Hydrochloride TabletsCGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls Chlorpromazine Hydrochloride TabletsCGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls Chlorpromazine Hydrochloride TabletsCGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls Chlorpromazine Hydrochloride TabletsCGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls Chlorpromazine Hydrochloride TabletsCGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls Chlorpromazine Hydrochloride TabletsCGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls Chlorpromazine Hydrochloride TabletsCGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls Succinylcholine Chloride InjectionFailed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation impurity.
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls Icosapent Ethyl Capsules 1 gramFailed Tablet/Capsule specifications; a product complaint was reported for burnt or melted capsules. This was determined to be a result of oxidation by leakage of capsule contents.
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls Esomeprazole Magnesium for Delayed-Release Oral SuspensionFailed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation product during Related Compounds testing during long term stability.
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls Esomeprazole Magnesium for Delayed-Release Oral SuspensionFailed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation product during Related Compounds testing during long term stability.
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls chlorproMAZINE Hydrochloride TabletsCGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls Venlafaxine TabletsPresence of Foreign Substance: Product complaint received for the presence of foreign material embedded resembling a metal shaving in one tablet.
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls Nelarabine InjectionFailed Impurities/Degradation Specifications
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls Nelarabine InjectionFailed Impurities/Degradation Specifications
-
Class IIIofficial
Zydus Pharmaceuticals (USA) Inc recalls Esomeprazole Magnesium for Delayed-Release Oral Suspension 40 mgLabeling: Not Elsewhere Classified - Wrong NDC number
-
Class IIIofficial
Zydus Pharmaceuticals (USA) Inc recalls Micafungin for injectionCross contamination with other products
-
Class IIIofficial
Zydus Pharmaceuticals (USA) Inc recalls Micafungin for injectionCross contamination with other products
-
Class IIIofficial
Zydus Pharmaceuticals (USA) Inc recalls Verapamil Hydrochloride InjectionCross contamination with other products.
-
Class IIIofficial
Zydus Pharmaceuticals (USA) Inc recalls Verapamil Hydrochloride InjectionCross contamination with other products.
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls Cyanocobalamin InjectionPresence of particulate matter: glass
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls Venlafaxine Hydrochloride Extended-Release CapsulesFailed Dissolution Specifications: Out-of-specification results observed for dissolution testing at the 8-hour and 12-hour pull intervals.
-
Class IIIofficial
Zydus Pharmaceuticals (USA) Inc recalls Estradiol Transdermal SystemFailed Impurities/Degradation Specifications.
-
Class IIIofficial
Zydus Pharmaceuticals (USA) Inc recalls Estradiol Transdermal SystemFailed Impurities/Degradation Specifications.
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls Oxybutynin Chloride Extended-Release Tablet USPFailed Dissolution Specifications-out-of-specification (OOS) test results observed for dissolution at the 6 month long term time point.
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls Oxybutynin Chloride Extended-Release Tablet USPFailed Dissolution Specifications-out-of-specification (OOS) test results observed for dissolution at the 6 month long term time point.
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls Oxybutynin Chloride Extended-Release Tablet USPFailed Dissolution Specifications-out-of-specification (OOS) test results observed for dissolution at the 6 month long term time point.
This page groups recalls by the company name the agency printed, so it can include different companies with similar names, and a recall may name a store or distributor rather than the maker. It counts the recalls in Recall Relay's records, not a company's whole history; an FDA recall that lists several products counts once. Open a recall to see its details and the agency's official notice, which is always the final word. Recall Relay isn't affiliated with any agency or with the companies named here.
Severity labels say where they come from: “official” is the agency's own class, “advisory” is based on the agency's safety warning, and “est. risk” is Recall Relay's estimate from the hazard description, not an agency classification.
Hear about the next one
Recall Relay can email you when a new recall mentions Zydus Pharmaceuticals (USA) Inc or any words you choose. Start with a free key (no card needed), then set up alerts on your account page.
Get recall alerts